# MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study

Study · id `cardio:ct-nct06543082` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06543082](<https://clinicaltrials.gov/study/NCT06543082>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06543082

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 490 participants.

## Technical summary

Registry record NCT06543082. Allocation not applicable; no masking; primary purpose treatment. Start 2024-08-05 (actual); primary completion 2028-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 490 participants (planned count; ClinicalTrials.gov record NCT06543082, source copy `cardio:ctgov-nct06543082-2026-02-18`, retrieved 2026-10-31)
- Started: 2024-08-05 (actual) (ClinicalTrials.gov record NCT06543082, source copy `cardio:ctgov-nct06543082-2026-02-18`, retrieved 2026-10-31)
- Primary completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT06543082, source copy `cardio:ctgov-nct06543082-2026-02-18`, retrieved 2026-10-31)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT06543082, source copy `cardio:ctgov-nct06543082-2026-02-18`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT06543082, source copy `cardio:ctgov-nct06543082-2026-02-18`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06543082-2026-02-18`, retrieved 2026-10-31)

## The registry's words

- Brief title: MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study
- Acronym: MACT II
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Colchicine 0.6 mg
- Lead sponsor: CHA University
- Lead sponsor class: OTHER
- Collaborator: Biotronik SE & Co. KG
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Colchicine (`cardio:colchicine`)
- Registry lists this organization as a collaborator: Biotronik SE & Co. KG (`cardio:org-biotronik-se-co-kg`)

## Provenance

Content hash: 9ff4d6815c198969bbf864071ad72b1011c8583b82d5e04764a76b9140e51e53
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
